Mirtazapine and restless leg syndrome: a case report.
Bonin
B
B
Vandel
P
P
Kantelip
J P
JP
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D053961:Azabicyclo Compounds; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003863:Depression / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000378:metabolism; D008297:Male; D008803:Mianserin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000078785:Mirtazapine; D010879:Piperazines / Q000627:therapeutic use; D012148:Restless Legs Syndrome / Q000139:chemically induced*; D014635:Valproic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists; D000929:Antidepressive Agents, Tricyclic; D053961:Azabicyclo Compounds; D065607:Cytochrome P-450 Enzyme Inhibitors; D007527:Isoenzymes; D010879:Piperazines; C515050:zopiclone; D008803:Mianserin; D014635:Valproic Acid; D003577:Cytochrome P-450 Enzyme System; D000078785:Mirtazapine; C004651:dipropylacetamide